Despite the still ongoing discussion regarding statin-induced myopathy, myositis, and rhabdomyolysis [17, 19, 23, 44] recent studies describe that the benefits of the treatment, outweigh the possible risks which, of note, are usually not relevant to DMD boys [21, 26]. The gene discussed is DMD; the disease is rhabdomyolysis.